Androgens and prostate cancer risk: A prospective study
- 11 June 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (11) , 1230-1237
Abstract
BACKGROUND Androgens have been implicated in prostate tumorigenesis, but prospective studies have overall reported no association between circulating levels of androgens and risk of prostate cancer. However, some recent studies have shown that a high level of testosterone increase the risk of non‐aggressive tumors but is associated with a decreased risk of aggressive tumors. METHODS We prospectively measured plasma levels of total testosterone, androstanediol glucuronide (A‐diol‐g) and sex hormone binding globuline (SHBG) and calculated estimated levels of free testosterone, in a nested case‐control study of 392 cases and 392 matched controls. RESULTS None of the studied hormones were significantly associated with prostate cancer risk in the full study group or in subgroups according to tumor aggressiveness. Odds ratios in the full study group, for top versus bottom quartile, was for total testosterone 1.25 (95% CI = 0.79–2.00; Ptrend = 0.51); free testosterone, 1.31 (95% CI = 0.82–2.07; Ptrend = 0.35); A‐diol‐g, 0.88 (95% CI = 0.59–1.33; Ptrend = 0.77); and for SHBG, 1.01 (95% CI = 0.64–1.58; Ptrend = 0.94). Conclusions We found no significant associations between androgen levels and risk of prostate cancer in this population‐based, non‐screened cohort. Prostate 67: 1230–1237, 2007.Keywords
This publication has 20 references indexed in Scilit:
- Circulating Steroid Hormones and the Risk of Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone TherapyCancer Epidemiology, Biomarkers & Prevention, 2005
- Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen EraCancer Epidemiology, Biomarkers & Prevention, 2005
- High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened CohortJournal of Clinical Oncology, 2004
- High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective studyInternational Journal of Cancer, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?Journal of Urology, 2000
- INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELSJournal of Urology, 1998
- Prospective Study of Sex Hormone Levels and Risk of Prostate CancerJNCI: Journal of the National Cancer Institute, 1996
- Representativeness of a single point plasma testosterone level for the long term hormonal milieu in menThe Journal of Clinical Endocrinology & Metabolism, 1992